Na Yang
About
Na Yang is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Na Yang has authored 36 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Na Yang's work include Acute Myocardial Infarction Research (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Na Yang is often cited by papers focused on Acute Myocardial Infarction Research (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Na Yang collaborates with scholars based in China, United States and Australia. Na Yang's co-authors include Jing Liu, Feng Tian, Yongchen Hao, Wei Ren Chen, Yun Dai Chen, Jing Wang, Dong Zhao, Changsheng Ma, Junbo Ge and Kathryn A. Taubert and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Heart Journal and Mayo Clinic Proceedings.
In The Last Decade
Na Yang
32 papers receiving 253 citations
Peers
Na Yang
E. Andrikou Greece
Rosa Maria Rahmi Garcia Brazil
Tadaaki Arimura Japan
Shaun G. Goodman Canada
Stephen Hippler United States
Hans-Ulrich Haering Germany
Ji‐Yong Jang South Korea
Huilei Zhao China
Toshiaki Ohkuma Australia
Frangiskos I. Parthenakis Greece
Citations per year, relative to Na Yang Na Yang (= 1×)
peers
E. Andrikou
Countries citing papers authored by Na Yang
Since
Specialization
Citations
This map shows the geographic impact of Na Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Yang more than expected).
Fields of papers citing papers by Na Yang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Na Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Yang. The network helps show where Na Yang may publish in the future.
Co-authorship network of co-authors of Na Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Na Yang. A scholar is included among the top collaborators of Na Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Yang. Na Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hao, Yongchen, Jun Liu, Na Yang, et al.. (2025). Blood pressure and in-hospital outcomes in patients hospitalized with atrial fibrillation: findings from the CCC-AF project. Hypertension Research. 48(4). 1331–1341.
2.
Yang, Na, Bo Wu, Lei Dai, et al.. (2025). Polystyrene bead ingestion promotes atherosclerosis plaque progression via BMP signaling in mice. Food and Chemical Toxicology. 202. 115455–115455.
3.
Hao, Yongchen, Jun Liu, Na Yang, et al.. (2025). Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet count. Archives of cardiovascular diseases. 118(5). 304–311.
4.
He, Liyun, Sang Hoon Han, Na Yang, et al.. (2025). Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis. Journal of Diabetes. 17(3). e70063–e70063.
5.
Yang, Na, et al.. (2024). The Role of P‐Wave Variables in Enhancing Prediction of New‐Onset Atrial Fibrillation in Patients With Acute Myocardial Infarction. Annals of Noninvasive Electrocardiology. 30(1). e70041–e70041.
6.
Yang, Na, et al.. (2024). Artemether ameliorates acetaminophen-induced liver injury through Nrf2 pathway. Biomedicine & Pharmacotherapy. 179. 117280–117280.
7.
He, Pengkang, Jie Jiang, Fangfang Fan, et al.. (2023). In-hospital therapies and determinants of treatment strategy selection in patients with atrial fibrillation and left ventricular systolic dysfunction in China: a retrospective study based on the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) project, 2015–2019. BMJ Open. 13(6). e070070–e070070.
8.
Ye, Yicong, Yongchen Hao, Xiliang Zhao, et al.. (2023). Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia. Thrombosis and Haemostasis. 125(3). 218–229.
9.
Wang, Chen, Chunyan Peng, Xueping Qiu, et al.. (2022). Development and Validation of a Nomogram to Assist Monitoring Nosocomial SARS-CoV-2 Infection of Hospitalized Patients. SHILAP Revista de lepidopterología.
10.
Zhou, Mengge, Jie Zhang, Jing Liu, et al.. (2022). Proton Pump Inhibitors and In-Hospital Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy. Mayo Clinic Proceedings. 97(4). 682–692.
11.
Liu, Jing, Jun Liu, Yongchen Hao, et al.. (2022). Association Between Early Oral β-Blocker Therapy and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction With Mild-Moderate Heart Failure: Findings From the CCC-ACS Project. Frontiers in Cardiovascular Medicine. 9. 828614–828614.
12.
Hu, Danqing, Yongchen Hao, Jun Liu, et al.. (2022). Inter-hospital transfer in patients with acute myocardial infarction in China: Findings from the improving care for cardiovascular disease in China-acute coronary syndrome project. Frontiers in Cardiovascular Medicine. 9. 1064690–1064690.
13.
Sun, Zhaoqing, Yongchen Hao, Jun Liu, et al.. (2022). Prevalence, awareness, treatment, and control rates of hypertension in patients hospitalized with atrial fibrillation in China: Findings from the CCC-AF project. Frontiers in Cardiovascular Medicine. 9. 970787–970787.
14.
Yang, Lijiao, Nan Ye, Guoqin Wang, et al.. (2021). The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project. BMC Cardiovascular Disorders. 21(1). 345–345.
15.
Li, Yan, Jeffrey E. Ming, Fangyuan Kong, et al.. (2020). Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover Study. Advances in Therapy. 37(11). 4660–4674.
16.
Hu, Guoliang, Mengge Zhou, Jing Liu, et al.. (2020). Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Global Heart. 15(1). 72–72.
17.
Wang, Lu, Tingting Guo, Jeffrey E. Ming, et al.. (2020). Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study. Advances in Therapy. 37(6). 2696–2709.
18.
Yang, Na, Jing Liu, Jun Liu, et al.. (2019). Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non–ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China–Acute Coronary Syndrome (CCC-ACS) project. American Heart Journal. 212. 80–90.
19.
Chen, Wei Ren, et al.. (2016). Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment–Elevation Myocardial Infarction. Circulation Cardiovascular Imaging. 9(12).
20.
Yang, Na, et al.. (2013). Clinical Analysis of Risk Factors and Lesion Characteristics of CoronaryArtery in Patients with Coronary Heart Disease.. Biomedical Research-tokyo. 24(1). 0.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by E. Andrikou Breakdown of academic impact, for papers by Rosa Maria Rahmi Garcia Breakdown of academic impact, for papers by Tadaaki Arimura Breakdown of academic impact, for papers by Shaun G. Goodman Breakdown of academic impact, for papers by Stephen Hippler Breakdown of academic impact, for papers by Hans-Ulrich Haering Breakdown of academic impact, for papers by Ji‐Yong Jang Breakdown of academic impact, for papers by Huilei Zhao Breakdown of academic impact, for papers by Toshiaki Ohkuma Breakdown of academic impact, for papers by Frangiskos I. Parthenakis